Stocks Comparison
Medline vs Resmed: revenue, profit, margins and growth compared
Medline brought in $28.4B of revenue in fiscal 2025, Resmed $5.7B in fiscal 2026. Medline kept 4.1% of its revenue as net profit, Resmed 26.9%. Free cash flow was $1.3B at Medline and $1.6B at Resmed.
Side by side, latest fiscal year
| MDLN | RMD | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2026 (June 30, 2026) |
| Revenue | $28.4B | $5.7B |
| Revenue growth | n/a | +9.9% |
| Net income | $1.2B | $1.5B |
| Net margin | 4.1% | 26.9% |
| Free cash flow | $1.3B | $1.6B |
| Free cash flow margin | 4.6% | 29.2% |
| Earnings per share (diluted) | -$0.01 | $10.43 |
| Cash | $1.9B | $1.5B |
| Debt | $12.6B | $399.4M |
| Price to earnings | n/a | 21.3 |
| Market value | $46.2B | $32B |
| Dividend yield | n/a | 1.08% |
| Rank by revenue in sector | #23 of 742 · Health care | #61 of 742 · Health care |
Over the years
MDLN $28.4BRMD $5.7B
MDLN $1.2BRMD $1.5B
MDLN 4.1%RMD 26.9%
MDLN +9.8%RMD +9.9%
MDLN $1.3BRMD $1.6B
Questions about Medline and Resmed
Which is bigger by revenue, Medline or Resmed?
Medline is bigger by revenue: $28.4B in fiscal 2025, against $5.7B for Resmed in fiscal 2026.
Which keeps more of its revenue as profit, Medline or Resmed?
Medline had a net margin of 4.1% in fiscal 2025; Resmed had 26.9% in fiscal 2026.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.